Rentrizin MR 35 Tablet is primarily utilised for the management of heart-related chest pain, known as angina. It belongs to the class of medications known as fatty acid oxidation inhibitors
Rentrizin MR 35 Tablet is prescribed for:
• Managing heart-related chest pain (angina)
• Preventing recurrent angina attacks
When taking Rentrizin MR 35 Tablet, adhere to these instructions:
• Swallow the tablet whole with a glass of water.
• Do not crush or chew the tablet.
• Take the tablet with food to enhance absorption.
• Do not exceed the recommended dosage without medical consultation.
• Do not discontinue the medication without consulting your doctor.
Rentrizin MR 35 Tablet is taken orally.
While using Rentrizin MR 35 Tablet, common side effects may include:
• Dizziness
• Headache
• Nausea
• Vomiting
• Weakness
Rentrizin MR 35 Tablet contains trimetazidine (35 mg), which works through these mechanisms:
• Energy Source Modulation: Trimetazidine alters the heart's metabolic pathway by shifting its energy source from fatty acids to glucose, which requires less oxygen for energy production.
• Oxygen Demand Reduction: By switching to glucose metabolism, the medication decreases the heart's oxygen demand, thus enhancing cardiac efficiency.
• Intracellular Energy Maintenance: Trimetazidine helps maintain intracellular energy levels, ensuring optimal functioning of cardiac muscle cells.
Exercise caution and consult your doctor before taking the medicine during pregnancy.
Discuss with your doctor before taking this tablet if you are breastfeeding.
Combining alcohol with this medicine may lead to excessive sedation and impaired judgement.
Consult your doctor if you have liver conditions before starting this medicine.
If you have kidney disease, caution is advised, and consultation with your doctor is necessary.
Avoid operating machinery or driving if you experience dizziness or drowsiness.
Inform your doctor of any known allergies before starting the medication.
Not recommended for individuals under the age of 18.
Use under medical supervision if over 70 years of age due to increased susceptibility to side effects.
Drug-Drug Interactions
• Sedatives: May increase sedation when taken with Rentrizin MR 35 Tablet.
• Anti-anginal Medications: May enhance the effects when combined with this medication.
Drug-Disease Interactions
• Kidney Disease: Use cautiously as dosage adjustments may be required.
Daily Dosage
• The daily dosage should be taken as advised by your doctor, tailored to your condition.
Missed Dose
• If you miss a dose, take it as soon as you remember. If it is close to the time for your next dose, skip the missed dose.
Overdose
• Symptoms of overdose may include dizziness and nausea. Seek medical guidance immediately.
• Store Rentrizin MR 35 Tablet in a cool, dry place, away from direct sunlight.
• Maintain a temperature not exceeding 30°C.
• Protect from moisture and keep out of reach of children.
• Discard expired medication and check expiry dates regularly.
• Engage in regular exercise following your doctor's advice to manage angina.
• Follow a heart-healthy diet, low in saturated fats and cholesterol, and rich in whole grains, fruits, and vegetables.
.avif)
%20(1).png)
.webp)